Home Europe EEA Joint Committee Decision of the EEA Joint Committee No 94/2025 of 8 May 2025...
Date: 2025-07-24 Category: Not Applicable State: Union Government Country: Europe

Decision of the EEA Joint Committee No 94/2025 of 8 May 2025 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2025/1378]

Issued by EEA Joint Committee · Secretariat-General

Research with AI Agent Chat with Document Generate Summary Translate Helpful Share Add to Project Create Task

Executive Summary & Key Takeaways

## Policy Summary: EEA Joint Committee Decision No. 94/2025 This document summarizes Decision No. 94/2025 of the EEA Joint Committee, adopted on May 8, 2025, which amends Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement. The decision incorporates two Commission Implementing Regulations into the EEA Agreement: 1. **Commission Implementing Regulation (EU) 2024/2878 of November 8, 2024:** This regulation approves the basic substance *Allium fistulosum*, processed, in accordance with Regulation (EC) No 1107/2009 and amends Commission Implementing Regulation (EU) No 540/2011. (OJ L, 2024/2878, 11.11.2024, ELI: http://data.europa.eu/eli/reg_impl/2024/2878/oj) 2. **Commission Implementing Regulation (EU) 2024/2848 of November 11, 2024:** This regulation amends Implementing Regulation (EU) No 540/2011 regarding the approval periods of the active substances fenpyrazamine and flumetralin. (OJ L, 2024/2848, 12.11.2024, ELI: http://data.europa.eu/eli/reg_impl/2024/2848/oj) The full text of Implementing Regulations (EU) 2024/2878 and (EU) 2024/2848 in Icelandic and Norwegian languages will be published in the EEA Supplement to the Official Journal of the European Union and shall be authentic. This Decision entered into force on May 9, 2025, following the completion of notifications required under Article 103(1) of the EEA Agreement. The decision will be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union. The President of the EEA Joint Committee at the time of adoption was Nicolas VON LINGEN. (ELI: http://data.europa.eu/eli/dec/2025/1378/oj)

Key Entities Referenced

EEA Joint Committee: The decision-making body responsible for managing the EEA Agreement. EEA Agreement: The Agreement on the European Economic Area. Annex II Technical regulations, standards, testing and certification to the EEA Agreement: A section of the EEA Agreement that is being amended by this decision. Commission Implementing Regulation EU 2024/2878: A European Union regulation approving the basic substance Allium fistulosum. Regulation EC No 1107/2009 of the European Parliament and of the Council: A European Union regulation concerning the placing of plant protection products on the market. Commission Implementing Regulation EU No 540/2011: A European Union regulation that is being amended by other regulations mentioned in the document. Commission Implementing Regulation EU 2024/2848: A European Union regulation amending Implementing Regulation EU No 540/2011 as regards the approval periods of fenpyrazamine and flumetralin. Brussels: The city where the decision was made.
Official Source Record View Original Source →
See Full Document Text
Official Journal EN of the European Union L series 2025/1378 24.7.2025 DECISION OF THE EEA JOINT COMMITTEENo 94/2025 of 8 May 2025 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2025/1378] THE EEA JOINT COMMITTEE, Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof, Whereas: (1) Commission Implementing Regulation (EU) 2024/2878 of 8 November 2024 approving the basic substance Allium fistulosum, processed, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011(1)is to be incorporated into the EEA Agreement. (2) Commission Implementing Regulation (EU) 2024/2848 of 11 November 2024 amending Implementing Regulation (EU) No 540/2011 as regards the approval periods of the active substances fenpyrazamine and flumetralin(2)is to be incorporated into the EEA Agreement. (3) Annex II to the EEA Agreement should therefore be amended accordingly, HAS ADOPTED THIS DECISION: Article 1 Chapter XV of Annex II to the EEA Agreement shall be amended as follows: 1. The following indents are added in point 13a (Commission Implementing Regulation (EU) No 540/2011): ‘— 32024 R 2878: Commission Implementing Regulation (EU) 2024/2878 of 8 November 2024 (OJ L, 2024/2878, 11.11.2024), — 32024 R 2848: Commission Implementing Regulation (EU) 2024/2848 of 11 November 2024 (OJ L, 2024/2848, 12.11.2024).’ 2. The following point is inserted after point 13zzzzzzzzzzzzzzza (Commission Implementing Regulation (EU) 2024/2806): ‘13zzzzzzzzzzzzzzzb.32024 R 2878: Commission Implementing Regulation (EU) 2024/2878 of 8 November 2024 approving the basic substance Allium fistulosum, processed, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 (OJ L, 2024/2878, 11.11.2024).’ Article 2 The texts of Implementing Regulations (EU) 2024/2878 and (EU) 2024/2848 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic. (1) OJ L, 2024/2878, 11.11.2024, ELI: http://data.europa.eu/eli/reg_impl/2024/2878/oj. (2) OJ L, 2024/2848, 12.11.2024, ELI: http://data.europa.eu/eli/reg_impl/2024/2848/oj. ELI: http://data.europa.eu/eli/dec/2025/1378/oj 1/2EN OJ L, 24.7.2025 Article 3 This Decision shall enter into force on 9 May 2025, provided that all the notifications under Article 103(1) of the EEA Agreement have been made(*). Article 4 This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union. Done at Brussels, 8 May 2025. For the EEA Joint Committee The President Nicolas VON LINGEN (*) No constitutional requirements indicated. 2/2 ELI: http://data.europa.eu/eli/dec/2025/1378/oj

Continue your research